(Q39544499)

English

The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis.

scientific article published on 26 July 2016

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

title

The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

author name string

Paolo Dapavo

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

Igor Vujic

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

Maria Teresa Fierro

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

Pietro Quaglino

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

language of work or name

English

0 references

publication date

26 July 2016

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

published in

Journal of the American Academy of Dermatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

volume

75

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

page(s)

736-739

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

Identifiers

DOI

10.1016/J.JAAD.2016.04.068

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 March 2020

PubMed publication ID

27473452

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27473452

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27473452%20AND%20SRC:MED&resulttype=core&format=json

(Q39544499)

The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)